Mateon Therapeutics Inc Common Stock
Why Robinhood?
You can watch MATN and buy or sell other stocks, ETFs, and their options commission-free!About MATN
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
MATN Key Statistics
Stock Snapshot
As of today, Mateon Therapeutics Inc Common Stock(MATN) shares are valued at $0.26. The company's market cap stands at 114.26M, with a P/E ratio of -8.83.
Mateon Therapeutics Inc Common Stock(MATN) stock opened on 2026-04-15 at —. The price climbed to — and dipped to —.
The Mateon Therapeutics Inc Common Stock(MATN)'s current trading volume is 0, compared to an average daily volume of 183.23K.
In the last year, Mateon Therapeutics Inc Common Stock(MATN) shares hit a 52-week high of $0.11 and a 52-week low of $0.02.
In the last year, Mateon Therapeutics Inc Common Stock(MATN) shares hit a 52-week high of $0.11 and a 52-week low of $0.02.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.